Orally administered atogepant was efficacious, safe, and tolerable for the prevention of migraine: results from a phase 2b/3 study

被引：0
|
作者：
Goadsby, P. J. [1 ]
Dodick, D. W. [2 ]
Ailani, J. [3 ]
Trugman, J. M. [4 ]
Finnegan, M. [4 ]
Lakkis, H. [4 ]
Lu, K. [4 ]
Szegedi, A. [4 ]
机构：
[1] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[2] Mayo Clin, Phoenix, AZ USA
[3] Medstar Georgetown Univ Hosp, Washington, DC USA
[4] Allergan Plc, Madison, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO3117
引用
收藏
页码：811 / 811
页数：1
相关论文
共 50 条
  • [31] Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability? Results from a Phase 2b Pilot Randomized Clinical Trial
    Seng, E. K.
    Singer, A.
    Metts, C.
    Grinberg, A. S.
    Patel, Z.
    Marzouk, M.
    Rosenberg, L.
    Day, M.
    Minen, M.
    Lipton, R. B.
    Buse, D. C.
    HEADACHE, 2019, 59 : 1 - 2
  • [32] SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: PHASE 2B/3 SELECTION STUDY AND LONGTERM EXTENSION RESULTS
    Morison, Ben
    Schreiber, Stefan
    Watanabe, Mamoru
    Yun, Chohee
    Zhou, Yan
    Zhao, Sally
    Hsieh, Jeremy
    Moerch, Ulrik
    Rogler, Gerhard
    Loftus, Edward V.
    GUT, 2021, 70 : A6 - A6
  • [33] Effect of Linaclotide On IBS-Symptoms in the First Week of Treatment: Results from a Phase 2B Study
    Lembo, Anthony J.
    Johnston, Jeffrey M.
    Lavins, Bernard J.
    MacDougall, James E.
    Schneier, Harvey
    Shiff, Steven J.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A30 - A31
  • [34] Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
    Glorieux, Francis H.
    Langdahl, Bente
    Chapurlat, Roland
    De Beur, Suzanne Jan
    Sutton, Vernon Reid
    Poole, Kenneth E. S.
    Dahir, Kathryn M.
    Orwoll, Eric S.
    Willie, Bettina M.
    Mikolajewicz, Nicholas
    Zimmermann, Elizabeth
    Hosseinitabatabaei, Seyedmahdi
    Ominsky, Michael S.
    Saville, Chris
    Clancy, James
    Macinnon, Alastair
    Mistry, Arun
    Javaid, Muhammad K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 (09) : 1215 - 1228
  • [35] Eptinezumab for Prevention of Chronic migraine: Results of 2 Infusions in the Phase 3 PROMISE-2 (Prevention of Migraine via Intravenous Eptinezumab Safety and Efficacy-2) Trial
    Kudrow, David
    Lipton, Richard
    Silberstein, Stephen
    Cady, Roger
    Schaeffler, Barbara
    Biondi, David
    Smith, Jeff
    NEUROLOGY, 2019, 92 (15)
  • [36] BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY
    Van der Heijde, D.
    Deodhar, A.
    Gensler, L. S.
    Poddubnyy, D.
    Kivitz, A.
    Dougados, M.
    De Peyrecave, N.
    Oortgiesen, M.
    Vaux, T.
    Fleurinck, C.
    Baraliakos, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 332 - 333
  • [37] TARIBAVIRIN EXPOSURE ANALYSIS FROM A PREVIOUS PHASE 3 TRIAL CORRELATES WITH PHASE 2B WEIGHT BASED DOSING INTERIM RESULTS
    Pockros, Paul
    Jacobson, Ira M.
    Bacon, Bruce R.
    Afdhal, Nezam H.
    Poordad, Fred
    Chun, Eric
    Hammond, Janet
    HEPATOLOGY, 2008, 48 (04) : 1138A - 1139A
  • [38] Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integrated Results from a Phase 1/2a and an Ongoing Phase 2b
    Altman, Jessica K.
    Zuckerman, Tsila
    Frankfurt, Olga
    Luger, Selina M.
    Bixby, Dale L.
    Kota, Vamsi
    Burch, Micah M.
    Wolach, Ofir
    Levi, Itai
    Gourevitch, Anna
    Ram, Ron
    Flaishon, Liat
    Tessler, Shoshi
    Gengrinovitch, Stela
    Ben Yakar, Ruth
    Rowe, Jacob M.
    BLOOD, 2019, 134
  • [39] Comparison of Abdominal Pain Endpoints: Results from a Phase 2b Study of Linaclotide in Adults with IBS-C
    Lavins, Bernard
    MacDougall, James
    Shiff, Steven
    Schneier, Harvey
    Lembo, Anthony
    Johnston, Jeffrey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S486 - S486
  • [40] Patient experiences following Parkinson's disease treatment with inhaled levodopa: Results from a Phase 2b study
    LeWitt, P.
    Niyazov, A.
    Sedkov, A.
    Murck, H.
    Guo, A.
    MOVEMENT DISORDERS, 2016, 31 : S677 - S677
12345